Skip Nav Destination
Issues
1 September 2011
-
Cover Image
Cover Image
Immunofluorescent confocal image of CD68+ macrophages (green) and folate receptor-alpha expression on the epithelium (red) within primary mammary tumors from MMTV-PyMT transgenic mice. For further details, please see Daldrup-Link and coworkers on page 5695 in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Issue Sections
Highlights
CCR Translations
CCR New Strategies
Statistics in Clinical Cancer Research
Molecular Pathways
Special Report
Human Cancer Biology
Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC
Luc Friboulet; Daniel Barrios-Gonzales; Frédéric Commo; Ken André Olaussen; Stephan Vagner; Julien Adam; Aïcha Goubar; Nicolas Dorvault; Vladimir Lazar; Bastien Job; Benjamin Besse; Pierre Validire; Philippe Girard; Ludovic Lacroix; Johanna Hasmats; Fabienne Dufour; Fabrice André; Jean-Charles Soria
Telomere Attrition and Decreased Fetuin-A Levels Indicate Accelerated Biological Aging and Are Implicated in the Pathogenesis of Colorectal Cancer
Fraser Maxwell; Liane M. McGlynn; Hannah C. Muir; Dinesh Talwar; Michaela Benzeval; Tony Robertson; Campbell S. Roxburgh; Donald C. McMillan; Paul G. Horgan; Paul G. Shiels
Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers
Thomas Reinert; Charlotte Modin; Francisco M. Castano; Philippe Lamy; Tomasz K. Wojdacz; Lise Lotte Hansen; Carsten Wiuf; Michael Borre; Lars Dyrskjøt; Torben F. Ørntoft
Cancer Therapy: Preclinical
PRAME-Specific Allo-HLA–Restricted T Cells with Potent Antitumor Reactivity Useful for Therapeutic T-Cell Receptor Gene Transfer
Avital L. Amir; Dirk M. van der Steen; Marleen M. van Loenen; Renate S. Hagedoorn; Renate de Boer; Michel D.G. Kester; Arnoud H. de Ru; Gert-Jan Lugthart; Cees van Kooten; Pieter S. Hiemstra; Inge Jedema; Marieke Griffioen; Peter A. van Veelen; J.H. Frederik Falkenburg; Mirjam H.M. Heemskerk
Imaging, Diagnosis, Prognosis
Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients
Yang Xie; Guanghua Xiao; Kevin R. Coombes; Carmen Behrens; Luisa M. Solis; Gabriela Raso; Luc Girard; Heidi S. Erickson; Jack Roth; John V. Heymach; Cesar Moran; Kathy Danenberg; John D. Minna; Ignacio I. Wistuba
Cancer Therapy: Clinical
Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients
W. Joost Lesterhuis; I. Jolanda M. de Vries; Gerty Schreibelt; Annechien J.A. Lambeck; Erik H.J.G. Aarntzen; Joannes F.M. Jacobs; Nicole M. Scharenborg; Mandy W.M.M. van de Rakt; Annemiek J. de Boer; Sandra Croockewit; Michelle M. van Rossum; Roel Mus; Wim J.G. Oyen; Otto C. Boerman; Sophie Lucas; Gosse J. Adema; Cornelis J.A. Punt; Carl G. Figdor
T-Cell Immune Function in Tumor, Skin, and Peripheral Blood of Advanced Stage Melanoma Patients: Implications for Immunotherapy
Esther P.M. Tjin; Debby Konijnenberg; Gabrielle Krebbers; Henk Mallo; Jan W. Drijfhout; Kees L.M.C. Franken; Chantal M.A.M. van der Horst; Jan D. Bos; Omgo E. Nieweg; Bin B.R. Kroon; John B.A.G. Haanen; Cornelis J.M. Melief; Florry A. Vyth-Dreese; Rosalie M. Luiten
Multicenter Phase II Trial of Temozolomide in Mycosis Fungoides/Sézary Syndrome: Correlation with O6-Methylguanine-DNA Methyltransferase and Mismatch Repair Proteins
Christiane Querfeld; Steven T. Rosen; Joan Guitart; Alfred Rademaker; David S. Pezen; M. Eileen Dolan; Joseph Baron; Daniel B. Yarosh; Francine Foss; Timothy M. Kuzel
Early Tumor Progression Associated with Enhanced EGFR Signaling with Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer
Athanassios Argiris; Austin G. Duffy; Shivaani Kummar; Nicole L. Simone; Yoshio Arai; Seungwon W. Kim; Susan F. Rudy; Vishnu R. Kannabiran; Xinping Yang; Minyoung Jang; Zhong Chen; Nanette Suksta; Theresa Cooley-Zgela; Susmita G. Ramanand; Aarif Ahsan; Mukesh K. Nyati; John J. Wright; Carter Van Waes
Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c
Fred Saad; Sebastien Hotte; Scott North; Bernie Eigl; Kim Chi; Piotr Czaykowski; Lori Wood; Michael Pollak; Scott Berry; Jean-Baptiste Lattouf; Som D. Mukherjee; Martin Gleave; Eric Winquist; for the Canadian Uro-Oncology Group
Pharmacokinetic Dose-Scheduling Study of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors
Patricia M. LoRusso; Antonio Jimeno; Grace Dy; Alex Adjei; Jordan Berlin; Lawrence Leichman; Jennifer A. Low; Dawn Colburn; Ilsung Chang; Sravanthi Cheeti; Jin Y. Jin; Richard A. Graham
Predictive Biomarkers and Personalized Medicine
Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer
Armin Gerger; Anthony El-Khoueiry; Wu Zhang; Dongyun Yang; Harpreet Singh; Pierre Bohanes; Yan Ning; Thomas Winder; Melissa J. LaBonte; Peter M. Wilson; Leonor Benhaim; David Paez; Rita El-Khoueiry; Gudrun Absenger; Heinz-Josef Lenz
Tumor Engraftment in Nude Mice and Enrichment in Stroma- Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer
Ignacio Garrido-Laguna; Maria Uson; N.V. Rajeshkumar; Aik Choon Tan; Elizabeth de Oliveira; Collins Karikari; Maria C. Villaroel; Ana Salomon; Gretchen Taylor; Rajni Sharma; Ralph H. Hruban; Anirban Maitra; Daniel Laheru; Belén Rubio-Viqueira; Antonio Jimeno; Manuel Hidalgo
Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy
Xiang-Lin Tan; Ann M. Moyer; Brooke L. Fridley; Daniel J. Schaid; Nifang Niu; Anthony J. Batzler; Gregory D. Jenkins; Ryan P. Abo; Liang Li; Julie M. Cunningham; Zhifu Sun; Ping Yang; Liewei Wang
Letters to the Editor
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.